A citation-based method for searching scientific literature

H Abdel-Aziz, A Nahrstedt, F Petereit, T Windeck, M Ploch, E J Verspohl. Planta Med 2005
Times Cited: 30







List of co-cited articles
137 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research.
Badreldin H Ali, Gerald Blunden, Musbah O Tanira, Abderrahim Nemmar. Food Chem Toxicol 2008
504
23

Anti-emetic principles of Magnolia obovata bark and Zingiber officinale rhizome.
T Kawai, K Kinoshita, K Koyama, K Takahashi. Planta Med 1994
58
20

Inhibition of cytotoxic drug-induced vomiting in suncus by a ginger constituent.
J Yamahara, H Q Rong, Y Naitoh, T Kitani, H Fujimura. J Ethnopharmacol 1989
32
20

Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.
M Barann, G Molderings, M Brüss, H Bönisch, B W Urban, M Göthert. Br J Pharmacol 2002
146
16

Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs.
S S Sharma, V Kochupillai, S K Gupta, S D Seth, Y K Gupta. J Ethnopharmacol 1997
59
16

[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo.
Eok-Cheon Kim, Jeong-Ki Min, Tae-Yoon Kim, Shin-Jeong Lee, Hyun-Ok Yang, Sanghwa Han, Young-Myeong Kim, Young-Guen Kwon. Biochem Biophys Res Commun 2005
152
16


Ginger--chemistry, technology, and quality evaluation: part 1.
V S Govindarajan. Crit Rev Food Sci Nutr 1982
114
16

Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles.
S Chrubasik, M H Pittler, B D Roufogalis. Phytomedicine 2005
232
16


The effect of extracts from ginger rhizome on inflammatory mediator production.
R C Lantz, G J Chen, M Sarihan, A M Sólyom, S D Jolad, B N Timmermann. Phytomedicine 2007
138
16

Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats.
Su-zhen Jiang, Ning-sheng Wang, Sui-qing Mi. Biopharm Drug Dispos 2008
42
16


Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects.
Suzanna M Zick, Zora Djuric, Mack T Ruffin, Amie J Litzinger, Daniel P Normolle, Sara Alrawi, Meihua Rose Feng, Dean E Brenner. Cancer Epidemiol Biomarkers Prev 2008
138
16

Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
Anu Kochanujan Pillai, Kamlesh K Sharma, Yogendra K Gupta, Sameer Bakhshi. Pediatr Blood Cancer 2011
65
16

Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways.
Muhammad Nabeel Ghayur, Anwarul Hassan Gilani, Maria B Afridi, Peter J Houghton. Vascul Pharmacol 2005
69
16



Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger.
Q R Huang, M Iwamoto, S Aoki, N Tanaka, K Tajima, J Yamahara, Y Takaishi, M Yoshida, T Tomimatsu, Y Tamai. Chem Pharm Bull (Tokyo) 1991
48
13


Ginger-chemistry, technology, and quality evaluation: part 2.
V S Govindarajan. Crit Rev Food Sci Nutr 1982
58
13

The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis.
Nathorn Chaiyakunapruk, Nantawarn Kitikannakorn, Surakit Nathisuwan, Kittiboon Leeprakobboon, Chutchai Leelasettagool. Am J Obstet Gynecol 2006
92
13



Examination of the pharmacokinetics of active ingredients of ginger in humans.
Yanke Yu, Suzanna Zick, Xiaoqin Li, Peng Zou, Benjamin Wright, Duxin Sun. AAPS J 2011
53
13

Ginger and its pungent constituents non-competitively inhibit activation of human recombinant and native 5-HT3 receptors of enteric neurons.
J Walstab, D Krüger, T Stark, T Hofmann, I E Demir, G O Ceyhan, B Feistel, M Schemann, B Niesler. Neurogastroenterol Motil 2013
31
13

Increasing effect of ethanol on 5-HT3 receptor-mediated 14C-guanidinium influx in N1E-115 neuroblastoma cells.
M Barann, K Ruppert, M Göthert, H Bönisch. Naunyn Schmiedebergs Arch Pharmacol 1995
28
10


Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.
Sanjay P Akhani, Santosh L Vishwakarma, Ramesh K Goyal. J Pharm Pharmacol 2004
72
10

Zingiber officinale (ginger)--an antiemetic for day case surgery.
S Phillips, R Ruggier, S E Hutchinson. Anaesthesia 1993
92
10

Ginger treatment of hyperemesis gravidarum.
W Fischer-Rasmussen, S K Kjaer, C Dahl, U Asping. Eur J Obstet Gynecol Reprod Biol 1991
168
10

Gastrointestinal motility enhancing effect of ginger and its active constituents.
J Yamahara, Q R Huang, Y H Li, L Xu, H Fujimura. Chem Pharm Bull (Tokyo) 1990
71
10

Molecular targets of dietary agents for prevention and therapy of cancer.
Bharat B Aggarwal, Shishir Shishodia. Biochem Pharmacol 2006
10


A nonpungent component of steamed ginger--[10]-shogaol--increases adrenaline secretion via the activation of TRPV1.
Yusaku Iwasaki, Akihito Morita, Takahito Iwasawa, Kenji Kobata, Youko Sekiwa, Yasujiro Morimitsu, Kikue Kubota, Tatsuo Watanabe. Nutr Neurosci 2006
85
10




Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects.
M Barann, W Meder, Z Dorner, M Brüss, H Bönisch, M Göthert, B W Urban. Naunyn Schmiedebergs Arch Pharmacol 2000
25
12


Effects of ginger on motion sickness susceptibility and gastric function.
J J Stewart, M J Wood, C D Wood, M E Mims. Pharmacology 1991
54
10

Ginger: an ethnomedical, chemical and pharmacological review.
M Afzal, D Al-Hadidi, M Menon, J Pesek, M S Dhami. Drug Metabol Drug Interact 2001
106
10

Modulation of macrophage functions by compounds isolated from Zingiber officinale.
Eun Mi Koh, Hye Jin Kim, Sohee Kim, Woo Hyuck Choi, Yeon Hee Choi, Shi Yong Ryu, Young Sup Kim, Woo Suk Koh, Shin-Young Park. Planta Med 2009
35
10

Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
G J Molderings, K Schmidt, H Bönisch, M Göthert. Naunyn Schmiedebergs Arch Pharmacol 1996
44
6



Structure-antiemetic-activity of some diarylheptanoids and their analogues.
Y Yang, K Kinoshita, K Koyama, K Takahashi, S Kondo, K Watanabe. Phytomedicine 2002
28
7

An update on GABAA receptors.
A K Mehta, M K Ticku. Brain Res Brain Res Rev 1999
516
6

Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
A C Hargreaves, M J Gunthorpe, C W Taylor, S C Lummis. Mol Pharmacol 1996
62
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.